C27H43NO8 (509.2988518)

Narbomycin

C28H47NO7 (509.3352352)

A macrolide antibiotic that is narbonolide having a 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residue attached at position 6. It is biosynthesised by Streptomyces venezuelae.

2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol

C33H39N3O2 (509.3042114)

FDA permitted light stabiliser for food-contact olefinic polymers. FDA permitted light stabiliser for food-contact olefinic polymers

LysoPE(0:0/20:0)

(2-Aminoethoxy)[(2R)-3-hydroxy-2-(icosanoyloxy)propoxy]phosphinic acid

C25H52NO7P (509.34812120000004)

LysoPE(0:0/20:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

LysoPC(17:0/0:0)

(2-{[(2R)-3-(heptadecanoyloxy)-2-hydroxypropyl phosphono]oxy}ethyl)trimethylazanium

C25H52NO7P (509.34812120000004)

LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

LysoPE(20:0/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-(icosanoyloxy)propoxy]phosphinic acid

C25H52NO7P (509.34812120000004)

LysoPE(20:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

Cholylthreonine

3-hydroxy-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)butanoic acid

C28H47NO7 (509.3352352)

Cholylthreonine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylthreonine consists of the bile acid cholic acid conjugated to the amino acid Threonine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylthreonine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylthreonine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

Colforsin daropate

(5-acetyloxy-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-6-yl) 3-(dimethylamino)propanoate

C27H43NO8 (509.2988518)

Landiolol

N-(2-{[3-(4-{3-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-oxopropyl}phenoxy)-2-hydroxypropyl]amino}ethyl)morpholine-4-carboximidate

C25H39N3O8 (509.2737014)

7,12,18-trihydroxy-16,18-dimethyl-21-acetoxy-10-phenyl-(11)-cytochalasa-5,13,19-trien-1-one|cytochalasin Z11

C30H39NO6 (509.2777234)

1,2-Dioctanoyl PC

1,2-bis(O-octanoyl)-sn-glyceryl-phophorylcholine

C24H48NO8P (509.3117378)

His Val Leu Lys

C24H43N7O5 (509.33255080000004)

Val Thr Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C24H39N5O7 (509.2849344)

Phosphatidylethanolamine lyso 20:0

C25H52NO7P (509.34812120000004)

C27H43NO8_Cevane-3,4,7,14,15,16,20-heptol, 4,9-epoxy-, (3beta,4alpha,7alpha,15alpha,16beta)

NCGC00180429-03_C27H43NO8_Cevane-3,4,7,14,15,16,20-heptol, 4,9-epoxy-, (3beta,4alpha,7alpha,15alpha,16beta)-

C27H43NO8 (509.2988518)

(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,16,22,23-heptol

(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,16,22,23-heptol

C27H43NO8 (509.2988518)

1-heptadecanoyl-sn-glycero-3-phosphocholine

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

A lysophosphatidylcholine 17:0 in which the acyl group at position 1 is 1-heptadecanoyl and the hydroxy group at position 2 is unsubstituted. CONFIDENCE standard compound; INTERNAL_ID 262

1-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C23H44NO9P (509.2753544)

PS(P-18:0/0:0)

1-(1Z-octadecenyl)-glycero-3-phosphoserine

C24H48NO8P (509.3117378)

Cysorb uv-1164

2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol

C33H39N3O2 (509.3042114)

NKH477

C27H43NO8 (509.2988518)

(3Z)-3-[{1,6-Dimethyl-2-[(1E,3E)-1,3-pentadien-1-yl]-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenyl}(hydroxy)methylene]-5-(1-hydroxyethyl)-2,4-pyrrolidinedione

C27H43NO8 (509.2988518)

PC 16:0

1-tetradecanoyl-2-acetyl-sn-glycero-3-phosphocholine

C24H48NO8P (509.3117378)

PC O-17:0

1-methyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

LPC 17:0

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

CONFIDENCE standard compound; INTERNAL_ID 262

LPC O-17:1;O

1-O-(2-methoxy-4Z-hexadecenyl)-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

LPE 20:0

2-eicosanoyl-sn-glycero-3-phosphoethanolamine

C25H52NO7P (509.34812120000004)

LPS 17:1

1-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C23H44NO9P (509.2753544)

LPS O-18:1

1-(1Z-octadecenyl)-glycero-3-phosphoserine

C24H48NO8P (509.3117378)

Clofilium tosylate

C28H44ClNO3S (509.27302640000005)

Cevin

Cevane-3,4,12,14,16,17,20-heptol,4,9-epoxy-, (3a,4a,16b)-

C27H43NO8 (509.2988518)

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids

Landiolol

C25H39N3O8 (509.2737014)

C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Barverine

C29H43N5O3 (509.3365728)

2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-iso-octyloxyphenyl)-1,3,5-triazine

C33H39N3O2 (509.3042114)

Acetyl tetrapeptide-3

C22H39N9O5 (509.3074004)

(11β,14ξ,16β)-9-Fluoro-11-hydroxy-16-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl (2H5)propanoate

C28H32D5FO7 (509.28370428999995)

SYBR(R) GREEN I NUCLEIC ACID GEL STAIN

C32H37N4S (509.2738782)

Unii-63P7W7886U

C29H40FN5O2 (509.3165872)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D065100 - CCR5 Receptor Antagonists

Colforsin daropate

C27H43NO8 (509.2988518)

(E)-2-((2-((3-(dimethylamino)propyl)(propyl)amino)-1-phenylquinolin-4(1H)-ylidene)methyl)-3-methylbenzo[d]thiazol-3-ium

C32H37N4S+ (509.2738782)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

1,2-Octanoylphosphatidylcholine

C24H48NO8P (509.3117378)

(3-Heptadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C25H52NO7P (509.34812120000004)

1-Oleoyl-sn-glycero-3-phospho-(1-sn-glycerol)

C24H46O9P- (509.28792960000004)

20-Hydroxyecdysonate

C27H41O9- (509.2750436)

a 2-acyl-sn-glycero-3-phosphoglycerol (n-C18:1)

C24H46O9P- (509.28792960000004)

Cholylthreonine

C28H47NO7 (509.3352352)

Veracevine

Cevane-3-beta,4-beta,12,14,16-beta,17,20-heptol, 4,9-epoxy-

C27H43NO8 (509.2988518)

A cyclic hemiketal that is cevane that has an oxygen bridge from the 4alpha to the 9 position and is substituted by hydroxy groups at the 3beta, 4beta, 12, 14, 16beta, 17, and 20 positions.

1-hexadecanoyl-2-methyl-sn-glycero-3-phosphocholine

N-[(5S,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

C29H39N3O5 (509.2889564)

N-icosanoyl-sn-glycero-3-phosphoethanolamine

C25H52NO7P (509.34812120000004)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-formyloxypropyl] octadecanoate

C24H48NO8P (509.3117378)

CID 5458458

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate

C24H48NO8P (509.3117378)

14-O-Acetylbrowniine

C27H43NO8 (509.2988518)

An acetate ester obtained by acetylation of the O-14 position of browniine.

Ultraviolet Absorbent UV-1164

2-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(octyloxy)phenol

C33H39N3O2 (509.3042114)

1-eicosanoyl-glycero-3-phosphoethanolamine

C25H52NO7P (509.34812120000004)

LysoPE(0:0/20:0)

C25H52NO7P (509.34812120000004)

1,2-dioctanoyl-sn-glycero-3-phosphocholine

C24H48NO8P (509.3117378)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as octanoyl.

1-pentadecyl-2-acetyl-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as pentadecyl and acetyl respectively.

1-tetradecanoyl-2-acetyl-sn-glycero-3-phosphocholine

C24H48NO8P (509.3117378)

1-hexadecyl-2-formyl-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and formyl respectively.

1-methyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as methyl and hexadecanoyl respectively.

1-(1Z-octadecenyl)-glycero-3-phosphoserine

C24H48NO8P (509.3117378)

1-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C23H44NO9P (509.2753544)

1-O-(2-methoxy-4Z-hexadecenyl)-sn-glycero-3-phosphocholine

C25H52NO7P (509.34812120000004)

lysophosphatidylcholine 17:0

C25H52NO7P (509.34812120000004)

An lysophosphatidylcholine in which the acyl group contains seventeen carbons and no double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolaminecholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

1-icosanoyl-sn-glycero-3-phosphoethanolamine

C25H52NO7P (509.34812120000004)

A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as icosanoyl.

2-icosanoyl-sn-glycero-3-phosphoethanolamine

C25H52NO7P (509.34812120000004)

A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as icosanoyl.

LdMePE(18:0)

C25H52NO7P (509.34812120000004)

PE(19:0)

PE(4:0_15:0)

C24H48NO8P (509.3117378)

BisMePE(18:0)

2-{[(1-{[(3z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylpentanoic acid

C25H43N5O6 (509.32131780000003)

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

C27H43NO8 (509.2988518)

(6s,8s,13s,14r,15s,16r,17r,18r,23r)-16-hydroxy-8,13,17,21-tetramethyl-25,26-dioxa-4-azaspiro[heptacyclo[14.7.2.1⁶,¹⁰.0¹,¹⁵.0³,¹³.0⁴,¹⁰.0¹⁸,²³]hexacosane-14,3'-oxolane]-2,20-diene-5',19-dione

(6s,8s,13s,14r,15s,16r,17r,18r,23r)-16-hydroxy-8,13,17,21-tetramethyl-25,26-dioxa-4-azaspiro[heptacyclo[14.7.2.1⁶,¹⁰.0¹,¹⁵.0³,¹³.0⁴,¹⁰.0¹⁸,²³]hexacosane-14,3'-oxolane]-2,20-diene-5',19-dione

C30H39NO6 (509.2777234)

8-{2-[(3r,7r,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadec-12-en-2-yl]ethyl}-1,5-dimethyl-7-oxo-6-oxabicyclo[3.2.1]octan-2-yl acetate

C32H47NO4 (509.3504902)